Stockscreener 앱 받기
0.8541
19.42%
-0.2059
시간 외 거래:
.88
0.0259
+3.03%
전일 마감가:
$1.06
열려 있는:
$0.976
하루 거래량:
52.19M
Relative Volume:
8.89
시가총액:
$164.84M
수익:
$1.57M
순이익/손실:
$-39.34M
주가수익비율:
-3.5766
EPS:
-0.2388
순현금흐름:
$-106.40M
1주 성능:
-25.08%
1개월 성능:
-25.73%
6개월 성능:
-54.08%
1년 성능:
-74.20%
1일 변동 폭
$0.81
$0.98
1주일 범위
$0.81
$1.22
52주 변동 폭
$0.81
$3.36
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
0.8541 | 204.58M | 1.57M | -39.34M | -106.40M | -0.2388 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-27 | 개시 | Barclays | Overweight |
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte Announces $20 Million Registered Direct Offering - TipRanks
Humacyte (Nasdaq: HUMA) prices $20M registered direct stock sale - Stock Titan
Humacyte secures $1.5M Saudi order – why did HUMA stock crash to record low today? - MSN
Humacyte stock price target maintained at $6 by BTIG on Saudi deal - Investing.com India
Humacyte Secures $1.5M Saudi Order – Why Did HUMA Stock Crash To Record Low Today? - Stocktwits
HUMA Drops 19.6%: Sharp Downturn Triggered by $20M Sale Amid Market Turbulence - Bitget
Humacyte Receives Purchase Commitment For Symvess Product In Saudi Arabia - marketscreener.com
Humacyte secures $1.5M Saudi Arabia purchase commitment - Investing.com
Humacyte Ends ATM Program, Highlights Symvess Global Expansion - TipRanks
Saudi hospitals to evaluate Humacyte vessel under $1.475M deal - Stock Titan
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock - Yahoo Finance Singapore
Humacyte (HUMA) halts $60M ATM as Symvess gains early sales and KSA deal - Stock Titan
Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN
Humacyte submits marketing application for Symvess in Israel By Investing.com - Investing.com South Africa
Risk Hedge: What is the long term forecast for Humacyte Inc stockWeekly Investment Report & Scalable Portfolio Growth Methods - baoquankhu1.vn
Humacyte stock rating reiterated at Buy by D. Boral Capital - Investing.com
Humacyte submits marketing application for Symvess in Israel - Investing.com
Humacyte Submits Marketing Authorization Application for Symvess in Israel for Vascular Trauma Repair - Bitget
Humacyte (NASDAQ:HUMA) Given Buy Rating at D. Boral Capital - MarketBeat
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair - The Manila Times
Battlefield-tested trauma vessel targets Israeli hospitals next - Stock Titan
Humacyte, Senseonics jump as Barclays issues new Overweight ratings - MSN
Humacyte, Inc. (NASDAQ:HUMA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Market Recap: Whats the fair value of Humacyte Inc Equity Warrant stock2026 Review & Community Driven Trade Alerts - baoquankhu1.vn
Aug Macro: What are Humacyte Inc Equity Warrants technical support levels2026 Risk Factors & Weekly High Momentum Picks - baoquankhu1.vn
Humacyte at Barclays Conference: Strategic Insights and Future Plans By Investing.com - Investing.com Canada
Risk Analysis: Will Humacyte Inc benefit from rising consumer demandQuarterly Trade Summary & Safe Entry Zone Identification - baoquankhu1.vn
Institution Moves: Does Humacyte Inc have a sustainable dividend2026 Action & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Humacyte jumps as US legislation backs bioengineered vessels - MSN
Humacyte, Inc. (HUMA) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
Humacyte, Inc. (HUMA) Is Viewed Favorably by Analysts: Does This Hold Up? - Bitget
HUMA Stock Is Soaring Today – Here’s Everything To Know About The DOD Funding Fueling The Surge - Stocktwits
Humacyte at TD Cowen Conference: Strategic Advances in Vascular Care By Investing.com - Investing.com Canada
Bioengineered tissue firm Humacyte lines up back-to-back March investor talks - Stock Titan
HUMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Humacyte, Inc. to Contact the Firm Today! - ACCESS Newswire
US Stocks Recap: Can Humacyte Inc sustain its profitabilityTrend Reversal & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Humacyte To Participate in Upcoming Investor Conferences - Bitget
Levels Update: What is the long term forecast for Humacyte Inc stock2025 Earnings Impact & Fast Moving Market Watchlists - baoquankhu1.vn
Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a Potential 527% Upside with Innovative Biotech Solutions - DirectorsTalk Interviews
HUMA Should I Buy - Intellectia AI
HUMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Humacyte, Inc. $HUMA Shares Sold by CenterBook Partners LP - MarketBeat
Will Humacyte Inc. Equity Warrant face regulatory challengesWeekly Gains Report & Free Community Supported Trade Ideas - mfd.ru
What’s the fair value of Humacyte Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - mfd.ru
Why Humacyte Inc. stock is favored by top institutions2025 Retail Activity & Fast Gaining Stock Strategy Reports - mfd.ru
Humacyte, Inc. (HUMA) Stock Analysis: Unpacking A 570% Potential Upside - DirectorsTalk Interviews
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet - MSN
D. Boral Capital Reiterates Buy Rating for Humacyte (NASDAQ:HUMA) - MarketBeat
Insider Trends: Should I invest in Humacyte Inc Equity Warrant before earningsJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Humacyte Announces Presentation of Symvess Long-Term Safety and Efficacy Results at VESS Meeting - Bitget
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting - The Manila Times
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):